Optum guides members and providers through important upcoming formulary updates. See multiple tabs of linked spreadsheet for Select, Premium & UM Changes.
Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
August 20, 2019 - The FDA approved US WorldMeds’ Myobloc (rimabotulinumtoxinB), for the treatment of chronic sialorrhea in adults.
Return to publications